Literature DB >> 19795394

Melanocytes in development and cancer.

Audrey Uong1, Leonard I Zon.   

Abstract

Melanocytes are pigment-producing cells in the skin of humans and other vertebrates. A number of genes involved in melanocyte development and vertebrate pigmentation have been characterized, largely through studies of a diversity of pigment mutations in a variety of species. Embryonic development of the melanocyte initiates with cell fate specification in the neural crest, which is then followed by cell migration and niche localization. Many genes involved in melanocyte development have also been implicated in the development of melanoma, an aggressive and fatal form of skin cancer that originates in the melanocyte. Although early stage melanomas that have not spread to the lymph nodes can be excised with little risk of recurrence, patients diagnosed with metastatic melanoma have a high mortality rate due to the resistance of most tumors to radiotherapy and chemotherapy. Transformed melanocytes that develop into melanomas proliferate abnormally and often begin to grow radially in the skin. Vertical growth can then follow this radial growth, leading to an invasion through the basement membrane into the underlying dermis and subsequent metastasis. It is still unclear, however, how a normal melanocyte becomes a melanoma cell, and how melanoma utilizes the properties of the normal melanocyte and its progenitors in its progression. The goal of this mini-review is to highlight the role of melanocyte developmental pathways in melanoma, and to discuss recent studies and tools being used to illuminate this connection.

Entities:  

Mesh:

Year:  2010        PMID: 19795394      PMCID: PMC2783760          DOI: 10.1002/jcp.21935

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  59 in total

Review 1.  The art and design of genetic screens: RNA interference.

Authors:  Michael Boutros; Julie Ahringer
Journal:  Nat Rev Genet       Date:  2008-06-03       Impact factor: 53.242

2.  Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.

Authors:  Vikas K Goel; Alexander J F Lazar; Carla L Warneke; Mark S Redston; Frank G Haluska
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

3.  Wnt signalling required for expansion of neural crest and CNS progenitors.

Authors:  M Ikeya; S M Lee; J E Johnson; A P McMahon; S Takada
Journal:  Nature       Date:  1997-10-30       Impact factor: 49.962

4.  MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes.

Authors:  T J Hemesath; E R Price; C Takemoto; T Badalian; D E Fisher
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

5.  Growth factors rescue cutaneous melanoma cells from apoptosis induced by knockdown of mutated (V 600 E) B-RAF.

Authors:  Claus Christensen; Per Guldberg
Journal:  Oncogene       Date:  2005-09-15       Impact factor: 9.867

6.  The melanocyte differentiation program predisposes to metastasis after neoplastic transformation.

Authors:  Piyush B Gupta; Charlotte Kuperwasser; Jean-Philippe Brunet; Sridhar Ramaswamy; Wen-Lin Kuo; Joe W Gray; Stephen P Naber; Robert A Weinberg
Journal:  Nat Genet       Date:  2005-09-04       Impact factor: 38.330

7.  BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma.

Authors:  E Elizabeth Patton; Hans R Widlund; Jeffery L Kutok; Kamden R Kopani; James F Amatruda; Ryan D Murphey; Stephane Berghmans; Elizabeth A Mayhall; David Traver; Christopher D M Fletcher; Jon C Aster; Scott R Granter; A Thomas Look; Charles Lee; David E Fisher; Leonard I Zon
Journal:  Curr Biol       Date:  2005-02-08       Impact factor: 10.834

8.  Early- and late-migrating cranial neural crest cell populations have equivalent developmental potential in vivo.

Authors:  C V Baker; M Bronner-Fraser; N M Le Douarin; M A Teillet
Journal:  Development       Date:  1997-08       Impact factor: 6.868

9.  Zebrafish pigmentation mutations and the processes of neural crest development.

Authors:  R N Kelsh; M Brand; Y J Jiang; C P Heisenberg; S Lin; P Haffter; J Odenthal; M C Mullins; F J van Eeden; M Furutani-Seiki; M Granato; M Hammerschmidt; D A Kane; R M Warga; D Beuchle; L Vogelsang; C Nüsslein-Volhard
Journal:  Development       Date:  1996-12       Impact factor: 6.868

10.  Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells.

Authors:  Mariko Moriyama; Masatake Osawa; Siu-Shan Mak; Toshiyuki Ohtsuka; Norio Yamamoto; Hua Han; Véronique Delmas; Ryoichiro Kageyama; Friedrich Beermann; Lionel Larue; Shin-Ichi Nishikawa
Journal:  J Cell Biol       Date:  2006-05-01       Impact factor: 10.539

View more
  46 in total

1.  The melanosomal protein PMEL17 as a target for antibody drug conjugate therapy in melanoma.

Authors:  Youjun Chen; Cecile Chalouni; Christine Tan; Robyn Clark; Rayna Venook; Rachana Ohri; Helga Raab; Ron Firestein; William Mallet; Paul Polakis
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

2.  Constitutive gray hair in mice induced by melanocyte-specific deletion of c-Myc.

Authors:  Irina Pshenichnaya; Karine Schouwey; Marzia Armaro; Lionel Larue; Paul S Knoepfler; Robert N Eisenman; Andreas Trumpp; Véronique Delmas; Friedrich Beermann
Journal:  Pigment Cell Melanoma Res       Date:  2012-05       Impact factor: 4.693

Review 3.  The evolving role of radiation therapy in the management of malignant melanoma.

Authors:  Niloufer Khan; Mohammad K Khan; Alex Almasan; Arun D Singh; Roger Macklis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-12       Impact factor: 7.038

Review 4.  Cranial neural crest migration: new rules for an old road.

Authors:  Paul M Kulesa; Caleb M Bailey; Jennifer C Kasemeier-Kulesa; Rebecca McLennan
Journal:  Dev Biol       Date:  2010-04-23       Impact factor: 3.582

5.  P-Rex1 is required for efficient melanoblast migration and melanoma metastasis.

Authors:  Colin R Lindsay; Samuel Lawn; Andrew D Campbell; William J Faller; Florian Rambow; Richard L Mort; Paul Timpson; Ang Li; Patrizia Cammareri; Rachel A Ridgway; Jennifer P Morton; Brendan Doyle; Shauna Hegarty; Mairin Rafferty; Ian G Murphy; Enda W McDermott; Kieran Sheahan; Katherine Pedone; Alexander J Finn; Pamela A Groben; Nancy E Thomas; Honglin Hao; Craig Carson; Jim C Norman; Laura M Machesky; William M Gallagher; Ian J Jackson; Leon Van Kempen; Friedrich Beermann; Channing Der; Lionel Larue; Heidi C Welch; Brad W Ozanne; Owen J Sansom
Journal:  Nat Commun       Date:  2011-11-22       Impact factor: 14.919

6.  Insights into the Role of PAX-3 in the Development of Melanocytes and Melanoma.

Authors:  Jessica Diann Hathaway; Azizul Haque
Journal:  Open Cancer J       Date:  2011-01-01

7.  STAP-2 Protein Expression in B16F10 Melanoma Cells Positively Regulates Protein Levels of Tyrosinase, Which Determines Organs to Infiltrate in the Body.

Authors:  Yuichi Sekine; Sumihito Togi; Ryuta Muromoto; Shigeyuki Kon; Yuichi Kitai; Akihiko Yoshimura; Kenji Oritani; Tadashi Matsuda
Journal:  J Biol Chem       Date:  2015-05-28       Impact factor: 5.157

Review 8.  Molecular and cellular pathogenesis of melanoma initiation and progression.

Authors:  Tarik Regad
Journal:  Cell Mol Life Sci       Date:  2013-03-27       Impact factor: 9.261

9.  From melanocyte to metastatic malignant melanoma.

Authors:  Bizhan Bandarchi; Linglei Ma; Roya Navab; Arun Seth; Golnar Rasty
Journal:  Dermatol Res Pract       Date:  2010-08-11

10.  Pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation.

Authors:  Jing Liu; Xinyu Qu; Liwei Shao; Yuan Hu; Xin Yu; Peixiang Lan; Qie Guo; Qiuju Han; Jian Zhang; Cai Zhang
Journal:  Cancer Biol Ther       Date:  2018-01-25       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.